-
1
-
-
33749059726
-
The neurobiology of multiple sclerosis: Genes, inflammation, and neurodegeneration
-
Hauser, S.L.; Oksenberg, J.R. The neurobiology of multiple sclerosis: Genes, inflammation, and neurodegeneration. Neuron 2006, 52, 61–76.
-
(2006)
Neuron
, vol.52
, pp. 61-76
-
-
Hauser, S.L.1
Oksenberg, J.R.2
-
2
-
-
48249139449
-
Multiple sclerosis: An immune or neurodegenerative disorder?
-
Trapp, B.D.; Nava, K.A. Multiple sclerosis: An immune or neurodegenerative disorder? Annu. Rev. Neurosci. 2008, 31, 247–269.
-
(2008)
Annu. Rev. Neurosci
, vol.31
, pp. 247-269
-
-
Trapp, B.D.1
Nava, K.A.2
-
3
-
-
0037039238
-
Prevalence estimates for MS in the United States and evidence of an increasing trend for women
-
Noonan, C.W.; Kathman, S.J.; White, M.C. Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology 2002, 58, 136–138.
-
(2002)
Neurology
, vol.58
, pp. 136-138
-
-
Noonan, C.W.1
Kathman, S.J.2
White, M.C.3
-
4
-
-
64149099359
-
Neuroprotection and neuroregeneration in multiple sclerosis
-
Stangel, M. Neuroprotection and neuroregeneration in multiple sclerosis. J. Neurol. 2008, 255, 77–81.
-
(2008)
J. Neurol
, vol.255
, pp. 77-81
-
-
Stangel, M.1
-
5
-
-
84906020064
-
Multiple sclerosis: Current knowledge and future outlook
-
Kamm, C.P.; Uitdehaag, B.M.; Polman, C.H. Multiple sclerosis: Current knowledge and future outlook. Eur. Neurol. 2014, 72, 132–141.
-
(2014)
Eur. Neurol
, vol.72
, pp. 132-141
-
-
Kamm, C.P.1
Uitdehaag, B.M.2
Polman, C.H.3
-
6
-
-
0342906187
-
Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
-
Lucchinetti, C.; Nruck, W.; Parisi, J.; Scheithaue, B.R.; Rodriguez, M.; Lassmann, H. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann. Neurol. 2000, 47, 707–717.
-
(2000)
Ann. Neurol
, vol.47
, pp. 707-717
-
-
Lucchinetti, C.1
Nruck, W.2
Parisi, J.3
Scheithaue, B.R.4
Rodriguez, M.5
Lassmann, H.6
-
7
-
-
0036546066
-
New concepts in the immunopathogenesis of multiple sclerosis
-
Hemmer, B.; Archelos, J.J.; Hartung, H.P. New concepts in the immunopathogenesis of multiple sclerosis. Nat. Rev. Neurosci. 2002, 3, 291–301.
-
(2002)
Nat. Rev. Neurosci
, vol.3
, pp. 291-301
-
-
Hemmer, B.1
Archelos, J.J.2
Hartung, H.P.3
-
8
-
-
37849033572
-
The therapeutic plasticity of neural stem/precursor cells in multiple sclerosis
-
Pluchino, S.; Martino, G. The therapeutic plasticity of neural stem/precursor cells in multiple sclerosis. J. Neurol. Sci. 2008, 265, 105–110.
-
(2008)
J. Neurol. Sci
, vol.265
, pp. 105-110
-
-
Pluchino, S.1
Martino, G.2
-
9
-
-
37849053110
-
Immunomodulation by neural stem cells
-
Ben-Hur, T. Immunomodulation by neural stem cells. J. Neurol. Sci. 2008, 265, 102–104.
-
(2008)
J. Neurol. Sci
, vol.265
, pp. 102-104
-
-
Ben-Hur, T.1
-
10
-
-
34047189953
-
New therapeutic approaches for multiple sclerosis
-
De Jager, P.L.; Hafler, D.A. New therapeutic approaches for multiple sclerosis. Annu. Rev. Med. 2007, 58, 417–432.
-
(2007)
Annu. Rev. Med
, vol.58
, pp. 417-432
-
-
De Jager, P.L.1
Hafler, D.A.2
-
11
-
-
70449253356
-
Heilung von Psoriasis
-
Schweckendiek, W. Heilung von Psoriasis. Med. Monatsschr. 1959, 13, 103–104.
-
(1959)
Med. Monatsschr
, vol.13
, pp. 103-104
-
-
Schweckendiek, W.1
-
12
-
-
65949111054
-
Fumaric Acid and its esters: An emerging treatment for multiple sclerosis
-
Moharregh-Khiabani, D.; Linker, R.A.; Gold, R.; Stangel, M. Fumaric Acid and its esters: An emerging treatment for multiple sclerosis. Curr. Neuropharmacol. 2009, 7, 60–64.
-
(2009)
Curr. Neuropharmacol
, vol.7
, pp. 60-64
-
-
Moharregh-Khiabani, D.1
Linker, R.A.2
Gold, R.3
Stangel, M.4
-
13
-
-
84866355653
-
CONFIRM Study Investigators. Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis
-
Fox, R.J.; Miller, D.H.; Phillips, J.T.; Hutchinson, M.; Havrdova, E.; Kita, M.; Raghupathi, K.; Novas, M.; Sweetser, M.T.; Viglietta, V.; et al. CONFIRM Study Investigators. Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. N. Engl. J. Med. 2012, 367, 1087–1097.
-
(2012)
N. Engl. J. Med.
, vol.367
, pp. 1087-1097
-
-
Fox, R.J.1
Miller, D.H.2
Phillips, J.T.3
Hutchinson, M.4
Havrdova, E.5
Kita, M.6
Raghupathi, K.7
Novas, M.8
Sweetser, M.T.9
Viglietta, V.10
-
14
-
-
84922895724
-
Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing-remitting multiple sclerosis (RRMS)
-
Gold, R.; Giovannoni, G.; Phillips, J.T.; Fox, R.J.; Zhang, A.; Meltzer, L.; Kurukulasuriya, N.C. Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing-remitting multiple sclerosis (RRMS). Mult. Scler. 2015, 21, 57–66.
-
(2015)
Mult. Scler
, vol.21
, pp. 57-66
-
-
Gold, R.1
Giovannoni, G.2
Phillips, J.T.3
Fox, R.J.4
Zhang, A.5
Meltzer, L.6
Kurukulasuriya, N.C.7
-
15
-
-
84878284582
-
BG-12 in multiple sclerosis
-
Phillips, J.T.; Fox, R.J. BG-12 in multiple sclerosis. Semin. Neurol. 2013, 33, 56–65.
-
(2013)
Semin. Neurol
, vol.33
, pp. 56-65
-
-
Phillips, J.T.1
Fox, R.J.2
-
16
-
-
84882750579
-
The fumaric acid ester BG-12: A new option in MS therapy
-
Lee, D.H.; Stangel, M.; Gold, R.; Linker, R.A. The fumaric acid ester BG-12: A new option in MS therapy. Expert Rev. Neurother. 2013, 13, 951–958.
-
(2013)
Expert Rev. Neurother
, vol.13
, pp. 951-958
-
-
Lee, D.H.1
Stangel, M.2
Gold, R.3
Linker, R.A.4
-
17
-
-
84863426841
-
Effects of dimethyl fumarate on neuroprotection and immunomodulation
-
Albrecht, P.; Bouchachia, I.; Goebels, N.; Henke, N.; Hofstetter, H.H.; Issberner, A.; Kovacs, Z.; Lewerenz, J.; Lisak, D.; Maher, P.; et al. Effects of dimethyl fumarate on neuroprotection and immunomodulation. J. Neuroinflamm. 2012, 9, doi:10.1186/1742-2094-9-163.
-
(2012)
J. Neuroinflamm
, vol.9
-
-
Albrecht, P.1
Bouchachia, I.2
Goebels, N.3
Henke, N.4
Hofstetter, H.H.5
Issberner, A.6
Kovacs, Z.7
Lewerenz, J.8
Lisak, D.9
Maher, P.10
-
18
-
-
40949153825
-
Role of Nrf2-dependent ARE-driven antioxidant pathway in neuroprotection
-
Li, J.; Calkins, M.J.; Johnson, D.A.; Johnson, J.A. Role of Nrf2-dependent ARE-driven antioxidant pathway in neuroprotection. Methods Mol. Biol. 2007, 399, 67–78.
-
(2007)
Methods Mol. Biol
, vol.399
, pp. 67-78
-
-
Li, J.1
Calkins, M.J.2
Johnson, D.A.3
Johnson, J.A.4
-
19
-
-
79958153194
-
The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and heme-oxygenase 1
-
Lin, S.X.; Lisi, L.; Russo, C.D.; Polak, P.E.; Sharp, A.; Weinberg, G.; Kalinin, S.; Feinstein, D.L. The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and heme-oxygenase 1. ASN Neuro 2011, 3, doi:10.1042/AN20100033.
-
(2011)
ASN Neuro
, vol.3
-
-
Lin, S.X.1
Lisi, L.2
Russo, C.D.3
Polak, P.E.4
Sharp, A.5
Weinberg, G.6
Kalinin, S.7
Feinstein, D.L.8
-
20
-
-
77956498372
-
Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions
-
Van Horssen, J.; Drexhage, J.A.; Flor, T.; Gerritsen, W.; van der Valk, P.; de Vries, H.E. Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions. Free Radic. Biol. Med. 2010, 49, 1283–1289.
-
(2010)
Free Radic. Biol. Med
, vol.49
, pp. 1283-1289
-
-
Van Horssen, J.1
Drexhage, J.A.2
Flor, T.3
Gerritsen, W.4
Van Der Valk, P.5
De Vries, H.E.6
-
21
-
-
58849110632
-
The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease
-
Calkins, M.J.; Johnson, D.A.; Townsend, J.A.; Vargas, M.R.; Dowell, J.A.; Williamson, T.P.; Kraft, A.D.; Lee, J.M.; Li, J.; Johnson, J.A.; et al. The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxid. Redox Signal. 2009, 11, 497–508.
-
(2009)
Antioxid. Redox Signal
, vol.11
, pp. 497-508
-
-
Calkins, M.J.1
Johnson, D.A.2
Townsend, J.A.3
Vargas, M.R.4
Dowell, J.A.5
Williamson, T.P.6
Kraft, A.D.7
Lee, J.M.8
Li, J.9
Johnson, J.A.10
-
22
-
-
78751703950
-
Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution
-
Taguchi, K.; Motohashi, H.; Yamamoto, M. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution. Genes Cells 2011, 16, 123–140.
-
(2011)
Genes Cells
, vol.16
, pp. 123-140
-
-
Taguchi, K.1
Motohashi, H.2
Yamamoto, M.3
-
23
-
-
79952136166
-
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
-
Linker, R.A.; Lee, D.H.; Ryan, S.; van Dam, A.M.; Conrad, R.; Bista, P.; Zeng, W.; Hronowsky, X.; Buko, A.; Chollate, S.; et al. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain 2011, 134, 678–692.
-
(2011)
Brain
, vol.134
, pp. 678-692
-
-
Linker, R.A.1
Lee, D.H.2
Ryan, S.3
Van Dam, A.M.4
Conrad, R.5
Bista, P.6
Zeng, W.7
Hronowsky, X.8
Buko, A.9
Chollate, S.10
-
24
-
-
77955478688
-
Effects of fumaric acids on cuprizone induced central nervous system de- and remyelination in the mouse
-
Moharregh-Khiabani, D.; Blank, A.; Skripuletz, T.; Miller, E.; Kotsiari, A.; Gudi, V.; Stangel, M. Effects of fumaric acids on cuprizone induced central nervous system de- and remyelination in the mouse. PLoS ONE 2010, 5, e11769.
-
(2010)
Plos ONE
, vol.5
-
-
Moharregh-Khiabani, D.1
Blank, A.2
Skripuletz, T.3
Miller, E.4
Kotsiari, A.5
Gudi, V.6
Stangel, M.7
-
25
-
-
70349333698
-
The Nrf2-ARE cytoprotective pathway in astrocytes
-
Vargas, M.R.; Johnson, J.A. The Nrf2-ARE cytoprotective pathway in astrocytes. Expert Rev. Mol. Med. 2009, 11, doi:10.1017/S1462399409001094.
-
(2009)
Expert Rev. Mol. Med
, vol.11
-
-
Vargas, M.R.1
Johnson, J.A.2
-
26
-
-
84858648216
-
Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (Erythroid-derived 2)-like 2 pathway
-
Scannevin, R.H.; Chollate, S.; Jung, M.Y.; Shackett, M.; Patel, H.; Bista, P.; Ryan, S.; Yamamoto, M.; Lukashev, M.; Rhodes, K.J.; et al. Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (erythroid-derived 2)-like 2 pathway. J. Pharmacol. Exp. Ther. 2012, 341, 274–284.
-
(2012)
J. Pharmacol. Exp. Ther.
, vol.341
, pp. 274-284
-
-
Scannevin, R.H.1
Chollate, S.2
Jung, M.Y.3
Shackett, M.4
Patel, H.5
Bista, P.6
Ryan, S.7
Yamamoto, M.8
Lukashev, M.9
Rhodes, K.J.10
-
27
-
-
0842304134
-
Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult
-
Kraft, A.D.; Johnson, D.A.; Johnson, J.A. Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J. Neurosci. 2004, 24, 1101–1112.
-
(2004)
J. Neurosci
, vol.24
, pp. 1101-1112
-
-
Kraft, A.D.1
Johnson, D.A.2
Johnson, J.A.3
-
28
-
-
0026526516
-
A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes
-
Reynolds, B.A.; Tetzlaff, W.; Weiss, S. A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J. Neurosci. 1992, 12, 4565–4574.
-
(1992)
J. Neurosci
, vol.12
, pp. 4565-4574
-
-
Reynolds, B.A.1
Tetzlaff, W.2
Weiss, S.3
-
29
-
-
33745684551
-
The therapeutic potential of neural stem cells
-
Martino, G.; Pluchino, S. The therapeutic potential of neural stem cells. Nat. Rev. Neurosci. 2006, 7, 395–406.
-
(2006)
Nat. Rev. Neurosci.
, vol.7
, pp. 395-406
-
-
Martino, G.1
Pluchino, S.2
-
30
-
-
0037418920
-
Neural stem cells: An overview
-
Galli, R.; Gritti, A.; Bonfanti, L.; Vescovi, A.L. Neural stem cells: An overview. Circ. Res. 2003, 92, 598–608.
-
(2003)
Circ. Res
, vol.92
, pp. 598-608
-
-
Galli, R.1
Gritti, A.2
Bonfanti, L.3
Vescovi, A.L.4
-
31
-
-
79551626268
-
Efficacy of fumaric acid esters in the R6/2 and YAC128 models of Huntington’s disease
-
Ellrichmann, G.; Petrasch-Parwez, E.; Lee, D.H.; Reick, C.; Arning, L.; Saft, C.; Gold, R.; Linker, R.A. Efficacy of fumaric acid esters in the R6/2 and YAC128 models of Huntington’s disease. PLoS ONE 2011, 6, e16172.
-
(2011)
Plos ONE
, vol.6
-
-
Ellrichmann, G.1
Petrasch-Parwez, E.2
Lee, D.H.3
Reick, C.4
Arning, L.5
Saft, C.6
Gold, R.7
Linker, R.A.8
-
32
-
-
0034997845
-
Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions
-
Pearson, G.; Robinson, F.; Beers Gibson, T.; Xu, B.E.; Karandikar, M.; Berman, K.; Cobb, M.H. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocr. Rev. 2001, 22, 153–183.
-
(2001)
Endocr. Rev.
, vol.22
, pp. 153-183
-
-
Pearson, G.1
Robinson, F.2
Beers Gibson, T.3
Xu, B.E.4
Karandikar, M.5
Berman, K.6
Cobb, M.H.7
-
33
-
-
79953145920
-
Opioid-Induced down-regulation of RGS4: Role of ubiquitination and implications for receptor cross-talk
-
Wang, Q.; Traynor, J.R. Opioid-Induced down-regulation of RGS4: Role of ubiquitination and implications for receptor cross-talk. J. Biol. Chem. 2011, 286, 7854–7864.
-
(2011)
J. Biol. Chem
, vol.286
, pp. 7854-7864
-
-
Wang, Q.1
Traynor, J.R.2
-
34
-
-
84859108053
-
P38(MAPK) and ERK1/2 dictate cell death/survival response to different pro-oxidant stimuli via p53 and Nrf2 in neuroblastoma cells SH-SY5Y
-
Filomeni, G.; Piccirillo, S.; Rotilio, G.; Ciriolo, M.R. p38(MAPK) and ERK1/2 dictate cell death/survival response to different pro-oxidant stimuli via p53 and Nrf2 in neuroblastoma cells SH-SY5Y. Biochem. Pharmacol. 2012, 83, 1349–1357.
-
(2012)
Biochem. Pharmacol
, vol.83
, pp. 1349-1357
-
-
Filomeni, G.1
Piccirillo, S.2
Rotilio, G.3
Ciriolo, M.R.4
-
35
-
-
84908153251
-
MDA-7/IL-24 inhibits Nrf2-mediated antioxidant response through activation of p38 pathway and inhibition of ERK pathway involved in cancer cell apoptosis
-
Tian, H.; Zhang, D.; Gao, Z.; Li, H.; Zhang, B.; Zhang, Q.; Li, L.; Cheng, Q.; Pei, D.; Zheng, J.; et al. MDA-7/IL-24 inhibits Nrf2-mediated antioxidant response through activation of p38 pathway and inhibition of ERK pathway involved in cancer cell apoptosis. Cancer Gene Ther. 2014, 21, 416–426.
-
(2014)
Cancer Gene Ther
, vol.21
, pp. 416-426
-
-
Tian, H.1
Zhang, D.2
Gao, Z.3
Li, H.4
Zhang, B.5
Zhang, Q.6
Li, L.7
Cheng, Q.8
Pei, D.9
Zheng, J.10
-
36
-
-
33745162188
-
Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration
-
Schilling, S.; Goelz, S.; Linker, R.; Luehder, F.; Gold, R. Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration. Clin. Exp. Immunol. 2006, 145, 101–107.
-
(2006)
Clin. Exp. Immunol.
, vol.145
, pp. 101-107
-
-
Schilling, S.1
Goelz, S.2
Linker, R.3
Luehder, F.4
Gold, R.5
-
37
-
-
56349160121
-
Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression
-
Van Horssen, J.; Schreibelt, G.; Drexhage, J.; Hazes, T.; Dijkstra, C.D.; van der Valk, P.; de Vries, H.E. Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression. Free Radic. Biol. Med. 2008, 45, 1729–1737.
-
(2008)
Free Radic. Biol. Med
, vol.45
, pp. 1729-1737
-
-
Van Horssen, J.1
Schreibelt, G.2
Drexhage, J.3
Hazes, T.4
Dijkstra, C.D.5
Van Der Valk, P.6
De Vries, H.E.7
-
38
-
-
84902578456
-
Nrf2 regulates neurogenesis and protects neural progenitor cells against Aβ toxicity
-
Kärkkäinen, V.; Pomeshchik, Y.; Savchenko, E.; Dhungana, H.; Kurronen, A.; Lehtonen, S.; Naumenko, N.; Tavi, P.; Levonen, A.L.; Yamamoto, M.; et al. Nrf2 regulates neurogenesis and protects neural progenitor cells against Aβ toxicity. Stem Cells 2014, 32, 1904–1916.
-
(2014)
Stem Cells
, vol.32
, pp. 1904-1916
-
-
Kärkkäinen, V.1
Pomeshchik, Y.2
Savchenko, E.3
Dhungana, H.4
Kurronen, A.5
Lehtonen, S.6
Naumenko, N.7
Tavi, P.8
Levonen, A.L.9
Yamamoto, M.10
-
39
-
-
0037763721
-
Regulatory mechanisms controlling gene expression mediated by the antioxidant response element
-
Nguyen, T.; Sherratt, P.J.; Pickett, C.B. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu. Rev. Pharmacol. Toxicol. 2003, 43, 233–260.
-
(2003)
Annu. Rev. Pharmacol. Toxicol
, vol.43
, pp. 233-260
-
-
Nguyen, T.1
Sherratt, P.J.2
Pickett, C.B.3
-
40
-
-
84894617624
-
Anti-Oxidizing effect of the dichloromethane and hexane fractions from Orostachys japonicus in LPS-stimulated RAW 264.7 cells via upregulation of Nrf2 expression and activation of MAPK signaling pathway
-
Lee, H.S.; Lee, G.S.; Kim, S.H.; Kim, H.K.; Suk, D.H.; Lee, D.S. Anti-Oxidizing effect of the dichloromethane and hexane fractions from Orostachys japonicus in LPS-stimulated RAW 264.7 cells via upregulation of Nrf2 expression and activation of MAPK signaling pathway. BMB Rep. 2014, 47, 98–103.
-
(2014)
BMB Rep
, vol.47
, pp. 98-103
-
-
Lee, H.S.1
Lee, G.S.2
Kim, S.H.3
Kim, H.K.4
Suk, D.H.5
Lee, D.S.6
-
41
-
-
33847176551
-
MAPK phosphatases-regulating the immune response. Nat
-
Liu, Y.; Shepherd, E.G.; Nelin, L.D. MAPK phosphatases-regulating the immune response. Nat. Rev. Immunol. 2007, 7, 202–212.
-
(2007)
Rev. Immunol
, vol.7
, pp. 202-212
-
-
Liu, Y.1
Shepherd, E.G.2
Nelin, L.D.3
-
42
-
-
0242666198
-
Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:Quinone oxidoreductase-1 gene expression
-
Bloom, D.A.; Jaiswal, A.K. Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. J. Biol. Chem. 2003, 278, 44675–44682.
-
(2003)
J. Biol. Chem
, vol.278
, pp. 44675-44682
-
-
Bloom, D.A.1
Jaiswal, A.K.2
-
43
-
-
84901846753
-
5-HT1A receptor-mediated phosphorylation of extracellular signal-regulated kinases (ERK1/2) is modulated by regulator of G protein signaling protein 19
-
Wang, Q.; Terauchi, A.; Yee, C.H.; Umemori, H.; Traynor, J.R. 5-HT1A receptor-mediated phosphorylation of extracellular signal-regulated kinases (ERK1/2) is modulated by regulator of G protein signaling protein 19. Cell Signal. 2014, 26, 1846–1852.
-
(2014)
Cell Signal
, vol.26
, pp. 1846-1852
-
-
Wang, Q.1
Terauchi, A.2
Yee, C.H.3
Umemori, H.4
Traynor, J.R.5
-
44
-
-
0346525140
-
U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells
-
Hotokezaka, H.; Sakai, E.; Kanaoka, K.; Saito, K.; Matsuo, K.; Kitaura, H.; Yoshida, N.; Nakayama, K. U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells. J. Biol. Chem. 2002, 277, 47366–47372.
-
(2002)
J. Biol. Chem
, vol.277
, pp. 47366-47372
-
-
Hotokezaka, H.1
Sakai, E.2
Kanaoka, K.3
Saito, K.4
Matsuo, K.5
Kitaura, H.6
Yoshida, N.7
Nakayama, K.8
-
45
-
-
33749055328
-
NFkB functions in the nervous system: From development to disease
-
Memet, S. NFkB functions in the nervous system: From development to disease. Biochem. Pharmacol. 2006, 72, 1180–1195.
-
(2006)
Biochem. Pharmacol
, vol.72
, pp. 1180-1195
-
-
Memet, S.1
-
46
-
-
84892777247
-
The MEK/ERK pathway is the primary conduit for Borrelia burgdorferi-induced inflammation and P53-mediated apoptosis in oligodendrocytes
-
Parthasarathy, G.; Philipp, M.T. The MEK/ERK pathway is the primary conduit for Borrelia burgdorferi-induced inflammation and P53-mediated apoptosis in oligodendrocytes. Apoptosis 2014, 19, 76–89.
-
(2014)
Apoptosis
, vol.19
, pp. 76-89
-
-
Parthasarathy, G.1
Philipp, M.T.2
-
47
-
-
84894024670
-
Rapid identification of Keap1–Nrf2 small-molecule inhibitors through structure-based virtual screening and hit-based substructure search
-
Zhuang, C.; Narayanapillai, S.; Zhang, W.; Sham, Y.Y.; Xing, C. Rapid identification of Keap1–Nrf2 small-molecule inhibitors through structure-based virtual screening and hit-based substructure search. J. Med. Chem. 2014, 57, 1121–1126.
-
(2014)
J. Med. Chem.
, vol.57
, pp. 1121-1126
-
-
Zhuang, C.1
Narayanapillai, S.2
Zhang, W.3
Sham, Y.Y.4
Xing, C.5
-
48
-
-
84897395747
-
Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis
-
Jiang, Z.Y.; Lu, M.C.; Xu, L.L.; Yang, T.T.; Xi, M.Y.; Xu, X.L.; Guo, X.K.; Zhang, X.J.; You, Q.D.; Sun, H.P.; et al. Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis. J. Med. Chem. 2014, 57, 2736–2745.
-
(2014)
J. Med. Chem.
, vol.57
, pp. 2736-2745
-
-
Jiang, Z.Y.1
Lu, M.C.2
Xu, L.L.3
Yang, T.T.4
Xi, M.Y.5
Xu, X.L.6
Guo, X.K.7
Zhang, X.J.8
You, Q.D.9
Sun, H.P.10
-
49
-
-
84879017773
-
Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism
-
Marcotte, D.; Zeng, W.; Hus, J.C.; McKenzie, A.; Hession, C.; Jin, P.; Bergeron, C.; Lugovskoy, A.; Enyedy, I.; Cuervo, H.; et al. Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism. Bioorg. Med. Chem. 2013, 21, 4011–4019.
-
(2013)
Bioorg. Med. Chem.
, vol.21
, pp. 4011-4019
-
-
Marcotte, D.1
Zeng, W.2
Hus, J.C.3
McKenzie, A.4
Hession, C.5
Jin, P.6
Bergeron, C.7
Lugovskoy, A.8
Enyedy, I.9
Cuervo, H.10
-
50
-
-
84876680052
-
Discovery of a small-molecule inhibitor and cellular probe of Keap1–Nrf2 protein-protein interaction
-
Hu, L.; Magesh, S.; Chen, L.; Wang, L.; Lewis, T.A.; Chen, Y.; Khodier, C.; Inoyama, D.; Beamer, L.J.; Emge, T.J.; et al. Discovery of a small-molecule inhibitor and cellular probe of Keap1–Nrf2 protein-protein interaction. Bioorg. Med. Chem. Lett. 2013, 23, 3039–3043.
-
(2013)
Bioorg. Med. Chem. Lett.
, vol.23
, pp. 3039-3043
-
-
Hu, L.1
Magesh, S.2
Chen, L.3
Wang, L.4
Lewis, T.A.5
Chen, Y.6
Khodier, C.7
Inoyama, D.8
Beamer, L.J.9
Emge, T.J.10
-
51
-
-
84939890610
-
Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study
-
Arnold, D.L.; Gold, R.; Kappos, L.; Bar-Or, A.; Giovannoni, G.; Selmaj, K.; Yang, M.; Zhang, R.; Stephan, M.; Sheikh, S.I.; et al. Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study. J. Neurol. 2014, 261, 1794–1802.
-
(2014)
J. Neurol
, vol.261
, pp. 1794-1802
-
-
Arnold, D.L.1
Gold, R.2
Kappos, L.3
Bar-Or, A.4
Giovannoni, G.5
Selmaj, K.6
Yang, M.7
Zhang, R.8
Stephan, M.9
Sheikh, S.I.10
-
52
-
-
84916931012
-
Effects of Delayed-Release Dimethyl Fumarate (DMF) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: An integrated analysis of the phase 3 DEFINE and CONFIRM studies
-
Kita, M.; Fox, R.J.; Gold, R.; Giovannoni, G.; Phillips, J.T.; Sarda, S.P.; Kong, J.; Viglietta, V.; Sheikh, S.I.; Okwuokenye, M.; et al. Effects of Delayed-Release Dimethyl Fumarate (DMF) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: An integrated analysis of the phase 3 DEFINE and CONFIRM studies. Clin. Ther. 2014, 36, 1958–1971.
-
(2014)
Clin. Ther
, vol.36
, pp. 1958-1971
-
-
Kita, M.1
Fox, R.J.2
Gold, R.3
Giovannoni, G.4
Phillips, J.T.5
Sarda, S.P.6
Kong, J.7
Viglietta, V.8
Sheikh, S.I.9
Okwuokenye, M.10
-
53
-
-
50949117527
-
Network inference algorithms elucidate Nrf2 regulation of mouse lung oxidative stress
-
Taylor, R.C.; Acquaah-Mensah, G.; Singhal, M.; Malhotra, D.; Biswal, S. Network inference algorithms elucidate Nrf2 regulation of mouse lung oxidative stress. PLoS Comput. Biol. 2008, 4, e1000166.
-
(2008)
Plos Comput. Biol
, vol.4
-
-
Taylor, R.C.1
Acquaah-Mensah, G.2
Singhal, M.3
Malhotra, D.4
Biswal, S.5
-
54
-
-
67650249743
-
Cytoprotective Nrf2 pathway is induced in chronically txnrd 1-deficient hepatocytes
-
Suvorova, E.S.; Lucas, O.; Weisend, C.M.; Rollins, M.F.; Merrill, G.F.; Capecchi, M.R.; Schmidt, E.E. Cytoprotective Nrf2 pathway is induced in chronically txnrd 1-deficient hepatocytes. PLoS ONE 2009, 4, e6158.
-
(2009)
Plos ONE
, vol.4
-
-
Suvorova, E.S.1
Lucas, O.2
Weisend, C.M.3
Rollins, M.F.4
Merrill, G.F.5
Capecchi, M.R.6
Schmidt, E.E.7
-
55
-
-
0035896748
-
Absence of mitochondrial superoxide dismutase results in a murine hemolytic anemia responsive to therapy with a catalytic antioxidant
-
Friedman, J.S.; Rebel, V.I.; Derby, R.; Bell, K.; Huang, T.T.; Kuypers, F.A.; Epstein, C.J.; Burakoff, S.J. Absence of mitochondrial superoxide dismutase results in a murine hemolytic anemia responsive to therapy with a catalytic antioxidant. J. Exp. Med. 2001, 193, 925–934.
-
(2001)
J. Exp. Med
, vol.193
, pp. 925-934
-
-
Friedman, J.S.1
Rebel, V.I.2
Derby, R.3
Bell, K.4
Huang, T.T.5
Kuypers, F.A.6
Epstein, C.J.7
Burakoff, S.J.8
-
56
-
-
84880379905
-
The Nrf2/SKN-1-dependent glutathione S-transferase π homologue GST-1 inhibits dopamine neuron degeneration in a Caenorhabditis elegans model of manganism
-
Settivari, R.; vanDuyn, N.; LeVora, J.; Nass, R. The Nrf2/SKN-1-dependent glutathione S-transferase π homologue GST-1 inhibits dopamine neuron degeneration in a Caenorhabditis elegans model of manganism. Neurotoxicology 2013, 38, 51–60.
-
(2013)
Neurotoxicology
, vol.38
, pp. 51-60
-
-
Settivari, R.1
Vanduyn, N.2
Levora, J.3
Nass, R.4
-
57
-
-
77951076084
-
Sulforaphane protects cortical neurons against 5-S-cysteinyldopamine-induced toxicity through the activation of ERK1/2, Nrf-2 and the upregulation of detoxification enzymes
-
Vauzour, D.; Buonfiglio, M.; Corona, G.; Chirafisi, J.; Vafeiadou, K.; Angeloni, C.; Hrelia, S.; Hrelia, P.; Spencer, J.P. Sulforaphane protects cortical neurons against 5-S-cysteinyldopamine-induced toxicity through the activation of ERK1/2, Nrf-2 and the upregulation of detoxification enzymes. Mol. Nutr. Food Res. 2010, 54, 532–542.
-
(2010)
Mol. Nutr. Food Res
, vol.54
, pp. 532-542
-
-
Vauzour, D.1
Buonfiglio, M.2
Corona, G.3
Chirafisi, J.4
Vafeiadou, K.5
Angeloni, C.6
Hrelia, S.7
Hrelia, P.8
Spencer, J.P.9
-
58
-
-
84876465755
-
Sulfiredoxin-1 protects PC12 cells against oxidative stress induced by hydrogen peroxide
-
Li, Q.; Yu, S.; Wu, J.; Zou, Y.; Zhao, Y. Sulfiredoxin-1 protects PC12 cells against oxidative stress induced by hydrogen peroxide. J. Neurosci. Res. 2013, 91, 861–870.
-
(2013)
J. Neurosci. Res
, vol.91
, pp. 861-870
-
-
Li, Q.1
Yu, S.2
Wu, J.3
Zou, Y.4
Zhao, Y.5
-
59
-
-
84862825378
-
C-Jun-dependent sulfiredoxin induction mediates BDNF protection against mitochondrial inhibition in rat cortical neurons
-
Wu, C.L.; Yin, J.H.; Hwang, C.S.; Chen, S.D.; Yang, D.Y.; Yang, D.I. c-Jun-dependent sulfiredoxin induction mediates BDNF protection against mitochondrial inhibition in rat cortical neurons. Neurobiol. Dis. 2012, 46, 450–462.
-
(2012)
Neurobiol. Dis
, vol.46
, pp. 450-462
-
-
Wu, C.L.1
Yin, J.H.2
Hwang, C.S.3
Chen, S.D.4
Yang, D.Y.5
Yang, D.I.6
-
60
-
-
36549034330
-
Identification of fasting-induced genes in the rat hypothalamus: Relationship with neuroprotection
-
Chiba, T.; Fujita, S.; Kubota, H.; Inoue, D.; Mizuno, A.; Komatsu, T.; Yamaza, H.; Higami, Y.; Shimokawa, I. Identification of fasting-induced genes in the rat hypothalamus: Relationship with neuroprotection. Ann. N. Y. Acad. Sci. 2007, 1119, 216–226.
-
(2007)
Ann. N. Y. Acad. Sci
, vol.1119
, pp. 216-226
-
-
Chiba, T.1
Fujita, S.2
Kubota, H.3
Inoue, D.4
Mizuno, A.5
Komatsu, T.6
Yamaza, H.7
Higami, Y.8
Shimokawa, I.9
-
61
-
-
33749128330
-
Determinants of CCL5-driven mononuclear cell migration across the blood–brain barrier. Implications for therapeutically modulating neuroinflammation
-
Ubogu, E.E.; Callahan, M.K.; Tucky, B.H.; Ransohoff, R.M. Determinants of CCL5-driven mononuclear cell migration across the blood–brain barrier. Implications for therapeutically modulating neuroinflammation. J. Neuroimmunol. 2006, 179, 132–144.
-
(2006)
J. Neuroimmunol
, vol.179
, pp. 132-144
-
-
Ubogu, E.E.1
Callahan, M.K.2
Tucky, B.H.3
Ransohoff, R.M.4
-
62
-
-
0033559346
-
Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
-
Sørensen, T.L.; Tani, M.; Jensen, J.; Pierce, V.; Lucchinetti, C.; Folcik, V.A.; Qin, S.; Rottman, J.; Sellebjerg, F.; Strieter, R.M.; et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Investig. 1999, 103, 807–815.
-
(1999)
J. Clin. Investig.
, vol.103
, pp. 807-815
-
-
Sørensen, T.L.1
Tani, M.2
Jensen, J.3
Pierce, V.4
Lucchinetti, C.5
Folcik, V.A.6
Qin, S.7
Rottman, J.8
Sellebjerg, F.9
Strieter, R.M.10
-
63
-
-
22144434812
-
Immunological patterns identifying disease course and evolution in multiple sclerosis patients
-
Furlan, R.; Rovaris, M.; Martinelli Boneschi, F.; Khademi, M.; Bergami, A.; Gironi, M.; Deleidi, M.; Agosta, F.; Franciotta, D.; Scarpini, E.; et al. Immunological patterns identifying disease course and evolution in multiple sclerosis patients. J. Neuroimmunol. 2005, 165, 192–200.
-
(2005)
J. Neuroimmunol
, vol.165
, pp. 192-200
-
-
Furlan, R.1
Rovaris, M.2
Martinelli Boneschi, F.3
Khademi, M.4
Bergami, A.5
Gironi, M.6
Deleidi, M.7
Agosta, F.8
Franciotta, D.9
Scarpini, E.10
-
64
-
-
33846856922
-
Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies
-
Szczuciński, A.; Losy, J. Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies. Acta Neurol. Scand. 2007, 115, 137–146.
-
(2007)
Acta Neurol. Scand
, vol.115
, pp. 137-146
-
-
Szczuciński, A.1
Losy, J.2
-
65
-
-
80051671298
-
CCL5 induces a pro-inflammatory profile in microglia in vitro
-
Skuljec, J.; Sun, H.; Pul, R.; Bénardais, K.; Ragancokova, D.; Moharregh-Khiabani, D.; Kotsiari, A.; Trebst, C.; Stangel, M. CCL5 induces a pro-inflammatory profile in microglia in vitro. Cell. Immunol. 2011, 270, 164–171.
-
(2011)
Cell. Immunol
, vol.270
, pp. 164-171
-
-
Skuljec, J.1
Sun, H.2
Pul, R.3
Bénardais, K.4
Ragancokova, D.5
Moharregh-Khiabani, D.6
Kotsiari, A.7
Trebst, C.8
Stangel, M.9
-
66
-
-
58149345561
-
G-Protein-Coupled receptor screen reveals a role for chemokine receptor CCR5 in suppressing microglial neurotoxicity
-
Gamo, K.; Kiryu-Seo, S.; Konishi, H.; Aoki, S.; Matsushima, K.; Wada, K.; Kiyama, H. G-Protein-Coupled receptor screen reveals a role for chemokine receptor CCR5 in suppressing microglial neurotoxicity. J. Neurosci. 2008, 28, 11980–11988.
-
(2008)
J. Neurosci
, vol.28
, pp. 11980-11988
-
-
Gamo, K.1
Kiryu-Seo, S.2
Konishi, H.3
Aoki, S.4
Matsushima, K.5
Wada, K.6
Kiyama, H.7
-
67
-
-
69249202262
-
The effect of interferon-beta on mouse neural progenitor cell survival and differentiation
-
Hirsch, M.; Knight, J.; Tobita, M.; Soltys, J.; Panitch, H.; Mao-Draayer, Y. The effect of interferon-beta on mouse neural progenitor cell survival and differentiation. Biochem. Biophys. Res. Commun. 2009, 388, 181–186.
-
(2009)
Biochem. Biophys. Res. Commun
, vol.388
, pp. 181-186
-
-
Hirsch, M.1
Knight, J.2
Tobita, M.3
Soltys, J.4
Panitch, H.5
Mao-Draayer, Y.6
-
68
-
-
79958766714
-
Cross-Talk between CD4+ T-cells and neural stem/progenitor cells
-
Knight, J.; Hackett, C.; Breton, J.; Mao-Draayer, Y. Cross-Talk between CD4+ T-cells and neural stem/progenitor cells. J. Neurol. Sci. 2011, 306, 121–128.
-
(2011)
J. Neurol. Sci
, vol.306
, pp. 121-128
-
-
Knight, J.1
Hackett, C.2
Breton, J.3
Mao-Draayer, Y.4
-
69
-
-
77957551487
-
Prdm16 promotes stem cell maintenance in multiple tissues, partly by regulating oxidative stress
-
Chuikov, S.; Levi, B.P.; Smith, M.L.; Morrison, S.J. Prdm16 promotes stem cell maintenance in multiple tissues, partly by regulating oxidative stress. Nat. Cell Biol. 2010, 12, 999–1006.
-
(2010)
Nat. Cell Biol
, vol.12
, pp. 999-1006
-
-
Chuikov, S.1
Levi, B.P.2
Smith, M.L.3
Morrison, S.J.4
-
70
-
-
79960221710
-
Stages of neuronal morphological development in vitro—An automated assay
-
Leach, M.K.; Naim, Y.I.; Feng, Z.Q.; Gertz, C.C.; Corey, J.M. Stages of neuronal morphological development in vitro—An automated assay. J. Neurosci. Methods 2011, 199, 192–198.
-
(2011)
J. Neurosci. Methods
, vol.199
, pp. 192-198
-
-
Leach, M.K.1
Naim, Y.I.2
Feng, Z.Q.3
Gertz, C.C.4
Corey, J.M.5
-
71
-
-
84874918845
-
Thioredoxin-Interacting protein mediates high glucose-induced reactive oxygen species generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells
-
Shah, A.; Xia, L.; Goldberg, H.; Lee, K.W.; Quaggin, S.E.; Fantus, I.G. Thioredoxin-Interacting protein mediates high glucose-induced reactive oxygen species generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells. J. Biol. Chem. 2013, 288, 6835–6848.
-
(2013)
J. Biol. Chem
, vol.288
, pp. 6835-6848
-
-
Shah, A.1
Xia, L.2
Goldberg, H.3
Lee, K.W.4
Quaggin, S.E.5
Fantus, I.G.6
-
72
-
-
84869043780
-
The predicted molecular weight of Nrf2: It is what it is not
-
Lau, A.; Tian, W.; Whitman, S.A.; Zhang, D.D. The predicted molecular weight of Nrf2: It is what it is not. Antioxid. Redox Signal. 2013, 18, 91–93.
-
(2013)
Antioxid. Redox Signal
, vol.18
, pp. 91-93
-
-
Lau, A.1
Tian, W.2
Whitman, S.A.3
Zhang, D.D.4
-
73
-
-
84934982970
-
-
(accessed on 1 May 2014)
-
Super-Array. Available online: http://www.superarray.com (accessed on 1 May 2014).
-
-
-
|